Ranger Investment Management L.P. Has $9.61 Million Position in Merit Medical Systems, Inc. $MMSI

Ranger Investment Management L.P. lessened its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 31.5% during the first quarter, HoldingsChannel reports. The institutional investor owned 139,425 shares of the medical instruments supplier’s stock after selling 64,180 shares during the period. Ranger Investment Management L.P.’s holdings in Merit Medical Systems were worth $9,611,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in MMSI. Los Angeles Capital Management LLC bought a new position in shares of Merit Medical Systems during the fourth quarter worth about $25,000. Maseco LLP bought a new stake in Merit Medical Systems in the fourth quarter valued at approximately $26,000. Torren Management LLC acquired a new stake in Merit Medical Systems during the 4th quarter valued at approximately $38,000. Covestor Ltd increased its position in Merit Medical Systems by 252.6% during the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after purchasing an additional 336 shares during the period. Finally, Danske Bank A S bought a new position in Merit Medical Systems during the 3rd quarter worth approximately $42,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on MMSI. Needham & Company LLC dropped their price target on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Robert W. Baird set a $83.00 price objective on shares of Merit Medical Systems in a research report on Friday, May 1st. Canaccord Genuity Group lowered their target price on shares of Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Wells Fargo & Company dropped their target price on shares of Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Finally, Weiss Ratings cut shares of Merit Medical Systems from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 8th. Eight investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $92.80.

Insider Buying and Selling at Merit Medical Systems

In other Merit Medical Systems news, insider Brian G. Lloyd acquired 2,000 shares of the stock in a transaction on Thursday, May 7th. The shares were purchased at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the completion of the acquisition, the insider owned 2,000 shares in the company, valued at approximately $125,240. This represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Lynne N. Ward sold 5,000 shares of the firm’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total transaction of $313,050.00. Following the completion of the transaction, the director directly owned 7,809 shares in the company, valued at $488,921.49. This trade represents a 39.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.70% of the company’s stock.

Merit Medical Systems Stock Up 2.9%

MMSI stock opened at $78.29 on Wednesday. The stock’s 50 day simple moving average is $68.73 and its 200 day simple moving average is $71.80. Merit Medical Systems, Inc. has a fifty-two week low of $59.74 and a fifty-two week high of $94.75. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 5.08. The company has a market cap of $4.67 billion, a P/E ratio of 33.89, a price-to-earnings-growth ratio of 2.37 and a beta of 0.52.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. The firm had revenue of $381.88 million during the quarter, compared to analysts’ expectations of $377.59 million. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.86 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, research analysts expect that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current fiscal year.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.